Xenetic Biosciences
XBIO
13 hedge funds and large institutions have $356K invested in Xenetic Biosciences in 2024 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
200% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 2
68% more capital invested
Capital invested by funds: $212K → $356K (+$144K)
44% more funds holding
Funds holding: 9 → 13 (+4)
2.64% more ownership
Funds ownership: 3.16% → 5.81% (+2.6%)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$64K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$54K |
| 3 |
LGF
LGT Group Foundation
Vaduz,
Liechtenstein
|
+$44.4K |
| 4 |
Renaissance Technologies
New York
|
+$39.1K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$6.68K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
S
Sachetta
Lynnfield,
Massachusetts
|
-$40.3K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.99K |
| 3 |
JP Morgan Chase
New York
|
-$876 |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$73 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $102K | +$39.1K | +9,700 | +61% |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $63.9K | +$64K | +15,859 | New |
|
|
3
Citadel Advisors
Miami,
Florida
| $53.9K | +$54K | +13,380 | New |
|
4
Geode Capital Management
Boston,
Massachusetts
| $47.9K | – | – | – |
|
|
LGF
5
LGT Group Foundation
Vaduz,
Liechtenstein
| $41.1K | +$44.4K | +11,000 | New |
|
|
S
6
Sachetta
Lynnfield,
Massachusetts
| $29.4K | -$40.3K | -10,000 | -58% |
|
|
JEST
7
JTC Employer Solutions Trustee
St Helier,
Jersey
| $11K | – | – | – |
|
|
8
UBS Group
Zurich,
Switzerland
| $6.61K | +$6.68K | +1,656 | New |
|
|
AIP
9
Alexis Investment Partners
Montgomery,
Texas
| $100 | +$101 | +25 | New |
|
|
10
Bank of America
Charlotte,
North Carolina
| $44 | -$73 | -18 | -62% |
|
|
SS
11
SBI Securities
Tokyo,
Japan
| $20 | +$20 | +5 | New |
|
|
DWM
12
Darwin Wealth Management
Tampa,
Florida
| $7 | – | – | – |
|
13
Morgan Stanley
New York
| $4 | – | – | – |
|
|
TRCT
14
Tower Research Capital (TRC)
New York
| – | -$2.99K | -692 | Closed |
|
|
15
JP Morgan Chase
New York
| – | -$876 | -200 | Closed |
|
XBIO Hedge Fund Activity: Q4 2024 in Review
13 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Xenetic Biosciences (XBIO) for Q4 2024, worth a combined $356K — up 68% from $212K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new XBIO positions and 2 closed out — a net gain of 4 holders — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $64K. The largest seller was Sachetta, cutting an estimated $40.3K.
- 13 institutional investors held Xenetic Biosciences (XBIO) as of Q4 2024, up from 9 in Q3 2024.
- Funds reported $356K of Xenetic Biosciences stock for Q4 2024, up 68% quarter-over-quarter.
- 6 funds opened new Xenetic Biosciences positions in Q4 2024 and 2 closed out, a net change of +4 holders.
- The largest Xenetic Biosciences buyer in Q4 2024 was Susquehanna International Group, an estimated $64K added.
- The largest Xenetic Biosciences seller in Q4 2024 was Sachetta, an estimated $40.3K sold.
Based on aggregated 13F filings for Q4 2024.